L870812

Known as: L-870812 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2013
0120042013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Coitally delivered microbicide gels containing antiretroviral drugs are important for HIV prevention. However, to date… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
OBJECTIVES Viral reservoirs-persistent residual virus despite combination antiretroviral therapy (cART)-remain an obstacle to… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2013
2013
Definitive treatment of HIV infection remains a critical but elusive goal, with persistence of residual virus even in the face of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
Conceptually, blocking human immunodeficiency virus type 1 (HIV-1) integration is the last possibility for preventing… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
We describe the efficacy of L-870812, an inhibitor of HIV-1 and SIV integrase, in rhesus macaques infected with the simian-human… (More)
Is this relevant?